Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes

Molecular Microbiology
J ClancyJ A Retsema

Abstract

Several streptococcal strains had an uncharacterized mechanism of macrolide resistance that differed from those that had been reported previously in the literature. This novel mechanism conveyed resistance to 14- and 15-membered macrolides, but not to 16-membered macrolides, lincosamides or analogues of streptogramin B. The gene encoding this phenotype was cloned by standard methods from total genomic digests of Streptococcus pyogenes 02C1064 as a 4.7 kb heterologous insert into the low-copy vector, pACYC177, and expressed in several Escherichia coli K-12 strains. The location of the macrolide-resistance determinant was established by functional analysis of deletion derivatives and sequencing. A search for homologues in the genetic databases confirmed that the gene is a novel one with homology to membrane-associated pump proteins. The macrolide-resistance coding sequence was subcloned into a pET23a vector and expressed from the inducible T7 promoter on the plasmid in E. coli BL21(DE3). Physiological studies of the cloned determinant, which has been named mefA for macrolide efflux, provide evidence for its mechanism of action in host bacteria. E.coli strains containing the cloned determinant maintain lower levels of intracellula...Continue Reading

Citations

Mar 25, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E Perez-TralleroJ M Marimon
Jul 29, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S FarmandR Berner
Mar 29, 2006·Current Allergy and Asthma Reports·Aleksandra K WierzbowskiGeorge G Zhanel
Apr 26, 2005·Current Infectious Disease Reports·Aleksandra K WierzbowskiGeorge G Zhanel
Jun 9, 2005·Advanced Drug Delivery Reviews·Ayush Kumar, Herbert P Schweizer
Sep 28, 2001·International Journal of Antimicrobial Agents·J Retsema, W Fu
Sep 19, 2003·International Journal of Antimicrobial Agents·Patrick ButayeStefan Schwarz
May 9, 1998·International Journal of Antimicrobial Agents·M C Roberts
Nov 24, 1999·International Journal of Antimicrobial Agents·L LatiniR Ronchetti
Dec 14, 1999·International Journal of Antimicrobial Agents·A PortilloC Torres
Oct 6, 1999·Current Opinion in Microbiology·D T Chu
Sep 27, 2002·Current Opinion in Pharmacology·Angela M Nilius, Zhenkun Ma
Dec 17, 2002·Symposium Series·K Poole
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V D ShortridgeR K Flamm
Jan 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Roland Leclercq
Jul 18, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Carmela CasconeStefania Stefani
Sep 10, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Maria SantagatiGianni Pozzi
Apr 23, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·R E C d'OliveiraA C D Castro
Mar 29, 2001·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·C AvanziniD Savoia
Jan 15, 2005·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sunjoo Kim, Nam Yong Lee
Dec 20, 2005·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·R PiresI Santos-Sanches
May 27, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Manel HraouiAnne Bouvet
May 14, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Karin SchwaigerJohann Bauer
Jan 13, 2005·ILAR Journal·Jean L Patterson, Richardo Carrion
Dec 10, 1999·The Journal of Antimicrobial Chemotherapy·H Carsenti-EtesseP Dellamonica
Jul 9, 1998·The Pediatric Infectious Disease Journal·B OrdenR Martínez
Jan 11, 2005·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Jari Jalava, Harri Marttila
May 4, 2011·Antimicrobial Agents and Chemotherapy·Scott T ChanceyDavid S Stephens
Oct 27, 2006·Antimicrobial Agents and Chemotherapy·Elisabeth AslangulRaymond Ruimy
Oct 28, 2009·Antimicrobial Agents and Chemotherapy·Andrea BrencianiEleonora Giovanetti
Nov 13, 2008·Antimicrobial Agents and Chemotherapy·Pietro E VaraldoEleonora Giovanetti
Oct 20, 2010·Antimicrobial Agents and Chemotherapy·Jun YinYonghong Yang
Jan 31, 2007·Antimicrobial Agents and Chemotherapy·Andrea BrencianiEleonora Giovanetti
Mar 18, 2000·Antimicrobial Agents and Chemotherapy·A PortilloC Torres
May 19, 2000·Antimicrobial Agents and Chemotherapy·E BingenD Deforche

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Bacterial Respiration

This feed focuses on cellular respiration in bacteria, known as bacterial respiration. Discover the latest research here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.